Drug Watch.
- Published in:
- Formulary, 2013, v. 48, n. 3, p. 122
- Publication type:
- Article
Works matching IS 1082801X AND DT 2013 AND VI 48 AND IP 3
Results: 25
1
2
Anti-VEGF drugs: Not just for retinal pathologies alone.
- Published in:
- 2013
- By:
- Publication type:
- Proceeding
3
Pediatric treatments for allergic ocular diseases improve.
- Published in:
- 2013
- By:
- Publication type:
- Proceeding
4
Statins use may reduce mortality in hepatocellular cancer by 30%.
- Published in:
- 2013
- By:
- Publication type:
- Proceeding
5
Know your options for cost-effective management of HE.
- Published in:
- Formulary, 2013, v. 48, n. 3, p. 118
- By:
- Publication type:
- Article
6
CPOE systems can reduce drug errors by almost half.
- Published in:
- Formulary, 2013, v. 48, n. 3, p. 117
- Publication type:
- Article
7
IOM report focuses on impact of counterfeit, substandard drugs.
- Published in:
- Formulary, 2013, v. 48, n. 3, p. 116
- By:
- Publication type:
- Article
8
What to do about multidrug-resistant gonorrhea.
- Published in:
- Formulary, 2013, v. 48, n. 3, p. 116
- Publication type:
- Article
9
Female sexual disorders: Treatment options in the pipeline.
- Published in:
- Formulary, 2013, v. 48, n. 3, p. 113
- By:
- Publication type:
- Article
10
Physician dispensing costs triple that of retail.
- Published in:
- Formulary, 2013, v. 48, n. 3, p. 112
- By:
- Publication type:
- Article
11
Researchers seek next class of anti-allergies.
- Published in:
- Formulary, 2013, v. 48, n. 3, p. 110
- By:
- Publication type:
- Article
12
An update on attention deficit/hyperactivity disorder.
- Published in:
- Formulary, 2013, v. 48, n. 3, p. 98
- By:
- Publication type:
- Article
13
FDA actions in brief.
- Published in:
- Formulary, 2013, v. 48, n. 3, p. 97
- Publication type:
- Article
14
New molecular entity.
- Published in:
- Formulary, 2013, v. 48, n. 3, p. 96
- Publication type:
- Article
15
First-time generic approvals.
- Published in:
- Formulary, 2013, v. 48, n. 3, p. 97
- Publication type:
- Article
16
Pipeline preview.
- Published in:
- Formulary, 2013, v. 48, n. 3, p. 96
- Publication type:
- Article
17
New strategies needed to reduce mortality associated with cardiometabolic risk factors in young people.
- Published in:
- Formulary, 2013, v. 48, n. 3, p. 95
- By:
- Publication type:
- Article
18
Vitamin D potency varies widely in dietary supplements.
- Published in:
- Formulary, 2013, v. 48, n. 3, p. 95
- By:
- Publication type:
- Article
19
Community-based intervention can help reduce mortality from opioid overdose.
- Published in:
- Formulary, 2013, v. 48, n. 3, p. 94
- By:
- Publication type:
- Article
20
Drug manufacturers seek payer feedback on new products.
- Published in:
- Formulary, 2013, v. 48, n. 3, p. 93
- By:
- Publication type:
- Article
21
Low-dose contraceptive patch comparable to combination oral contraceptive in safety, tolerability study.
- Published in:
- 2013
- Publication type:
- Proceeding
22
Patients who adhere to statin regimens are healthier, but higher drug spending makes overall care more costly.
- Published in:
- Formulary, 2013, v. 48, n. 3, p. 92
- Publication type:
- Article
23
High calcium intake could raise CV mortality in women.
- Published in:
- Formulary, 2013, v. 48, n. 3, p. 91
- Publication type:
- Article
24
MS specialty drug treatment costs climb to two-thirds of total MS treatment cost.
- Published in:
- Formulary, 2013, v. 48, n. 3, p. 88
- Publication type:
- Article
25
Aspirin use linked to age-related macular degeneration.
- Published in:
- Formulary, 2013, v. 48, n. 3, p. 85
- By:
- Publication type:
- Article